Xavier Forns, Jordi Bruix. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Antiviral Agents/therapeutic useDisease ProgressionHIV Infections/complicationsHepatitis C/complicationsHepatitis C/drug therapyHepatitis C/surgeryHumansInterferon alpha-2Interferon-alpha/therapeutic useLiver Cirrhosis/complicationsLiver TransplantationPolyethylene Glycols/therapeutic useRecombinant ProteinsRecurrenceReproducibility of ResultsRibavirin/therapeutic useTreatment Outcome
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2bpeginterferon alfa-2a
Year: 2010 PMID: 20334945 DOI: 10.1016/j.jhep.2010.01.021
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083